Terms: = Head and neck cancer AND ZNF521, EHZF, 25925, ENSG00000198795, MGC142208, MGC142182, DKFZp564D0764, Evi3
2 results:
1. Preliminary exploration of potential molecular therapeutic targets in recurrent and metastatic parathyroid carcinomas.
Cui M; Hu Y; Bi Y; Wang W; Wang M; Zhang X; Zhang R; Wang P; Su Z; Gao X; Wang J; Li Q; Liao Q; Zhao Y
Int J Cancer; 2019 Feb; 144(3):525-532. PubMed ID: 30362515
[TBL] [Abstract] [Full Text] [Related]
2. Cetuximab promotes epithelial to mesenchymal transition and cancer associated fibroblasts in patients with head and neck cancer.
Schmitz S; Bindea G; Albu RI; Mlecnik B; Machiels JP
Oncotarget; 2015 Oct; 6(33):34288-99. PubMed ID: 26437222
[TBL] [Abstract] [Full Text] [Related]
